0 followers
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Kleanthis G. Xanthopoulos
Generate Biomedicines
3 followers
GALY
1 follower
Synthekine
3 followers
Forge Biologics
2 followers
Obsidian Therapeutics
1 follower
TAE Life Sciences
3 followers
PMV Pharmaceuticals
1 follower
Ginkgo Bioworks
14 followers
Adaptive Biotechnologies
12 followers
Twist Bioscience
8 followers
Strand Therapeutics
3 followers
Discover companies